文献速递关节外科

全髋与全膝关节置换术中切口内万古霉素的系统综述与Meta分析:持续呼吁开展前瞻性随机试验

Systematic Review and Meta-Analysis of Intrawound Vancomycin in Total Hip and Total Knee Arthroplasty: A Continued Call for a Prospective Randomized Trial.
PubMed 文献 · J Arthroplasty · 2022-03-18

该系统综述与Meta分析纳入16项研究共33,731例患者,其中17,164例接受切口内万古霉素粉末(IVP),汇总分析显示IVP组假体周围关节感染(PJI)发生率降低(OR 0.46,P < .05),但证据质量低,作者认为在获得更高质量数据前不能推荐广泛使用。

要点

  • 汇总分析显示接受IVP的患者PJI发生率降低(OR 0.46,P < .05)。
  • 全膝关节置换术(TKA)与全髋关节置换术(THA)患者接受IVP后PJI率分别降低(OR 0.41,P < .05;OR 0.45,P < .05)。
  • 在获得更高质量数据(如随机对照试验)前,不能推荐广泛使用IVP。

核心结论

  • IVP可能降低初次和翻修全关节置换术(TJA)的PJI风险,但在获得更高质量数据(如随机对照试验)前不能推荐其广泛使用。
  • 本研究强调在关节置换外科医生普遍采用该做法之前,持续需要更严谨的研究。

研究设计与样本

  • 系统综述与Meta分析,检索PubMed和MEDLINE数据库,纳入在初次和翻修全髋关节置换术(THA)及全膝关节置换术(TKA)中使用IVP的研究。
  • 最终汇总16项研究,共33,731例患者,其中17,164例接受IVP。
  • 术后PJI数据采用随机效应模型合并,结果以比值比(OR)和95%置信区间(CI)报告,研究按效应估计值的方差倒数加权。

主要发现

  • 汇总分析中,接受IVP的患者PJI发生率降低(OR 0.46,P < .05)。
  • TKA患者接受IVP后PJI发生率降低(OR 0.41,P < .05),THA患者接受IVP后PJI发生率降低(OR 0.45,P < .05)。
  • 初次TKA和THA患者的汇总分析也显示PJI发生率降低(OR 0.44,P < .05)。
  • 翻修TKA和THA患者的汇总分析显示PJI发生率有类似降低(OR 0.30,P < .05)。

临床怎么用

  • 作者认为,IVP可能降低初次和翻修TJA的PJI风险,但在获得更高质量数据(如随机对照试验)前不能推荐其广泛使用。

局限性

  • 虽然未发现发表偏倚,但这些发现受限于可获得的低质量证据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Periprosthetic joint injection (PJI) is a rare, but life-altering complication of total joint arthroplasty (TJA). Though intrawound vancomycin powder (IVP) has been studied in other orthopedic subspecialties, its efficacy and safety in TJA has not been established. METHODS: PubMed and MEDLINE databases were used to identify studies utilizing IVP in primary and revision total hip (THA) and knee arthroplasty (TKA). Postoperative PJI data were pooled using random effect models with results reported as odds ratios (ORs) and 95% confidence intervals (CIs). Studies were weighted by the inverse variance of their effect estimates. RESULTS: Overall, 16 of the 1871 studies identified were pooled for final analysis, yielding 33,731 patients totally. Of these, 17 164 received IVP. In aggregate, patients who received IVP had a decreased rate of PJI (OR 0.46, P < .05). Separately, TKA and THA patients who received IVP had lower rates of PJI (OR 0.41, P < .05 and OR 0.45, P < .05, respectively). Aggregate analysis of primary TKA and THA patients also revealed a decreased PJI rate (OR 0.44, P < .05). Pooled revision TKA and THA patients had a similar decrease in PJI rates (OR 0.30, P < .05). Although no publication bias was appreciated, these findings are limited by the low-quality evidence available. CONCLUSION: While IVP may reduce the risk of PJI in primary and revision TJA, its widespread use cannot be recommended until higher-quality data, such as that obtained from randomized control trials, are available. This study underscores the continued need for more rigorous studies before general adoption of this practice by arthroplasty surgeons.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Movassaghi K, Wang JC, Gettleman BS, et al. Systematic Review and Meta-Analysis of Intrawound Vancomycin in Total Hip and Total Knee Arthroplasty: A Continued Call for a Prospective Randomized Trial. J Arthroplasty. 2022. PMID: 35314283. doi:10.1016/j.arth.2022.03.047

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。